{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:59:58Z","timestamp":1781013598918,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"crossref","award":["1402-1-101-65423"],"award-info":[{"award-number":["1402-1-101-65423"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10067-025-07764-7","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T02:13:10Z","timestamp":1762395190000},"page":"241-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Upregulation of RAF and RalGDS gene expression by TGF-\u03b2 in systemic sclerosis dermal fibroblasts: a controlled in vitro study"],"prefix":"10.1007","volume":"45","author":[{"given":"Fatemeh","family":"Bakhshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Mahalleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Kavosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jafarisavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooshin","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Enayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Madreseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Robat-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-2697","authenticated-orcid":false,"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Vodjgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"3","key":"7764_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117(3):557\u2013567","journal-title":"J Clin Invest"},{"issue":"19","key":"7764_CR2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360(19):1989\u20132003","journal-title":"N Engl J Med"},{"issue":"10103","key":"7764_CR3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685\u20131699","journal-title":"Lancet"},{"key":"7764_CR4","first-page":"105","volume":"4","author":"D Pattanaik","year":"2011","unstructured":"Pattanaik D, Brown M, Postlethwaite AE (2011) Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res 4:105\u2013125","journal-title":"J Inflamm Res"},{"issue":"7","key":"7764_CR5","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","volume":"60","author":"M Bairkdar","year":"2021","unstructured":"Bairkdar M et al (2021) Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology (Oxford) 60(7):3121\u20133133","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"7764_CR6","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/rheumatology\/kez532","volume":"59","author":"K Morrisroe","year":"2020","unstructured":"Morrisroe K et al (2020) The clinical and economic burden of systemic sclerosis related interstitial lung disease. Rheumatology (Oxford) 59(8):1878\u20131888","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"7764_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81(2):139\u2013153","journal-title":"Medicine (Baltimore)"},{"key":"7764_CR8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D et al (2015) Pathogenesis of systemic sclerosis. Front Immunol 6:272","journal-title":"Front Immunol"},{"key":"7764_CR9","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y et al (2015) Systemic sclerosis. Nat Rev Dis Primers 1:15002","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"7764_CR10","doi-asserted-by":"crossref","first-page":"C686","DOI":"10.1152\/ajpcell.00103.2011","volume":"302","author":"I Fuentes-Calvo","year":"2012","unstructured":"Fuentes-Calvo I et al (2012) H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. Am J Physiol Cell Physiol 302(4):C686\u2013C697","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6\u20137","key":"7764_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/emmm.200900043","volume":"1","author":"JM L\u00f3pez-Novoa","year":"2009","unstructured":"L\u00f3pez-Novoa JM, Nieto MA (2009) Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1(6\u20137):303\u2013314","journal-title":"EMBO Mol Med"},{"issue":"9","key":"7764_CR12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1681\/ASN.V1191600","volume":"11","author":"CC Sharpe","year":"2000","unstructured":"Sharpe CC et al (2000) Role of Ras isoforms in the stimulated proliferation of human renal fibroblasts in primary culture. J Am Soc Nephrol 11(9):1600\u20131606","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"7764_CR13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12079-017-0441-3","volume":"12","author":"K Tripathi","year":"2018","unstructured":"Tripathi K, Garg M (2018) Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer. J Cell Commun Signal 12(3):513\u2013527","journal-title":"J Cell Commun Signal"},{"key":"7764_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022129","author":"YE Zhang","year":"2017","unstructured":"Zhang YE (2017) Non-Smad signaling pathways of the TGF-\u03b2 family. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a022129","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"7764_CR15","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1158\/0008-5472.CAN-06-3851","volume":"67","author":"AJ Galliher","year":"2007","unstructured":"Galliher AJ, Schiemann WP (2007) Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67(8):3752\u20133758","journal-title":"Cancer Res"},{"issue":"17","key":"7764_CR16","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/sj.emboj.7601818","volume":"26","author":"MK Lee","year":"2007","unstructured":"Lee MK et al (2007) TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26(17):3957\u20133967","journal-title":"EMBO J"},{"key":"7764_CR17","first-page":"57","volume":"72","author":"R Khosravi-Far","year":"1998","unstructured":"Khosravi-Far R et al (1998) Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv Cancer Res 72:57\u2013107","journal-title":"Adv Cancer Res"},{"issue":"5","key":"7764_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jb\/mvv029","volume":"157","author":"R Shirakawa","year":"2015","unstructured":"Shirakawa R, Horiuchi H (2015) Ral GTPases: crucial mediators of exocytosis and tumourigenesis. J Biochem 157(5):285\u2013299","journal-title":"J Biochem"},{"issue":"1","key":"7764_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/j.1460-2075.1993.tb05662.x","volume":"12","author":"CF Albright","year":"1993","unstructured":"Albright CF et al (1993) Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J 12(1):339\u2013347","journal-title":"EMBO J"},{"issue":"6","key":"7764_CR20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.onc.1202425","volume":"18","author":"K Matsubara","year":"1999","unstructured":"Matsubara K et al (1999) Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation. Oncogene 18(6):1303\u20131312","journal-title":"Oncogene"},{"issue":"3","key":"7764_CR21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/aps.2014.129","volume":"36","author":"S Guin","year":"2015","unstructured":"Guin S, Theodorescu D (2015) The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer. Acta Pharmacol Sin 36(3):291\u2013297","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"7764_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.117.014415","volume":"70","author":"C Yan","year":"2018","unstructured":"Yan C, Theodorescu D (2018) RAL GTPases: biology and potential as therapeutic targets in cancer. Pharmacol Rev 70(1):1\u201311","journal-title":"Pharmacol Rev"},{"issue":"12","key":"7764_CR23","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1002\/cam4.1105","volume":"6","author":"AR Moghadam","year":"2017","unstructured":"Moghadam AR et al (2017) Ral signaling pathway in health and cancer. Cancer Med 6(12):2998\u20133013","journal-title":"Cancer Med"},{"issue":"3","key":"7764_CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ccr.2005.01.029","volume":"7","author":"A Gonz\u00e1lez-Garc\u00eda","year":"2005","unstructured":"Gonz\u00e1lez-Garc\u00eda A et al (2005) RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7(3):219\u2013226","journal-title":"Cancer Cell"},{"issue":"6","key":"7764_CR25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101\u20131108","journal-title":"Nat Protoc"},{"issue":"1","key":"7764_CR26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-022-02787-w","volume":"24","author":"M Rokni","year":"2022","unstructured":"Rokni M et al (2022) The role of endothelin and RAS\/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications. Arthritis Res Ther 24(1):108","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"7764_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3(1):11\u201322","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"7764_CR28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/01.ASN.0000057543.55318.8B","volume":"14","author":"HC Clarke","year":"2003","unstructured":"Clarke HC et al (2003) Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis. J Am Soc Nephrol 14(4):848\u2013854","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"7764_CR29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-2249.2001.01674.x","volume":"126","author":"A Katzav","year":"2001","unstructured":"Katzav A et al (2001) Treatment of MRL\/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin Exp Immunol 126(3):570\u2013577","journal-title":"Clin Exp Immunol"},{"key":"7764_CR30","doi-asserted-by":"crossref","first-page":"645044","DOI":"10.3389\/fphys.2021.645044","volume":"12","author":"I Fuentes-Calvo","year":"2021","unstructured":"Fuentes-Calvo I, Martinez-Salgado C (2021) Sos1 modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. Front Physiol 12:645044","journal-title":"Front Physiol"},{"issue":"5","key":"7764_CR31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1593\/neo.04241","volume":"6","author":"L Xie","year":"2004","unstructured":"Xie L et al (2004) Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6(5):603\u2013610","journal-title":"Neoplasia"},{"issue":"5","key":"7764_CR32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127888","volume":"10","author":"H Watanabe-Takano","year":"2015","unstructured":"Watanabe-Takano H et al (2015) DA-raf-mediated suppression of the Ras\u2013ERK pathway is essential for TGF-\u03b21-induced epithelial-mesenchymal transition in alveolar epithelial type 2 cells. PLoS ONE 10(5):e0127888","journal-title":"PLoS ONE"},{"issue":"5","key":"7764_CR33","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jcb.20458","volume":"95","author":"M Davies","year":"2005","unstructured":"Davies M et al (2005) Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 95(5):918\u2013931","journal-title":"J Cell Biochem"},{"issue":"2","key":"7764_CR34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1083\/jcb.200109037","volume":"156","author":"E Janda","year":"2002","unstructured":"Janda E et al (2002) Ras and TGF\u03b2 cooperatively regulate epithelial cell plasticity and metastasis\u202f: dissection of Ras signaling pathways. J Cell Biol 156(2):299\u2013314","journal-title":"J Cell Biol"},{"issue":"4","key":"7764_CR35","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2013.2","volume":"2","author":"S O'reilly","year":"2013","unstructured":"O\u2019reilly S et al (2013) Interleukin-6: a new therapeutic target in systemic sclerosis? Clin Transl Immunol 2(4):e4","journal-title":"Clin Transl Immunol"},{"issue":"22","key":"7764_CR36","doi-asserted-by":"crossref","first-page":"23098","DOI":"10.1074\/jbc.M311430200","volume":"279","author":"SW Xu","year":"2004","unstructured":"Xu SW et al (2004) Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK\/ERK. J Biol Chem 279(22):23098\u201323103","journal-title":"J Biol Chem"},{"issue":"13","key":"7764_CR37","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1016\/j.molimm.2007.02.022","volume":"44","author":"EY So","year":"2007","unstructured":"So EY et al (2007) Ras\/Erk pathway positively regulates Jak1\/STAT6 activity and IL-4 gene expression in Jurkat T cells. Mol Immunol 44(13):3416\u20133426","journal-title":"Mol Immunol"},{"issue":"25","key":"7764_CR38","doi-asserted-by":"crossref","first-page":"E1629","DOI":"10.1073\/pnas.1117640109","volume":"109","author":"K Singh","year":"2012","unstructured":"Singh K et al (2012) K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis. Proc Natl Acad Sci U S A 109(25):E1629\u2013E1637","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"7764_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21037\/tlcr-22-449","volume":"12","author":"D Dora","year":"2023","unstructured":"Dora D et al (2023) BRAF RNA is prognostic and widely expressed in lung adenocarcinoma. Transl Lung Cancer Res 12(1):27\u201341","journal-title":"Transl Lung Cancer Res"},{"issue":"54","key":"7764_CR40","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1038\/sj.onc.1208152","volume":"23","author":"H Tanami","year":"2004","unstructured":"Tanami H et al (2004) Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. Oncogene 23(54):8796\u20138804","journal-title":"Oncogene"},{"issue":"1","key":"7764_CR41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/ol.2010.219","volume":"2","author":"L Feng","year":"2011","unstructured":"Feng L et al (2011) Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma. Oncol Lett 2(1):59\u201363","journal-title":"Oncol Lett"},{"issue":"12","key":"7764_CR42","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1158\/0008-5472.CAN-07-6787","volume":"68","author":"C Montagut","year":"2008","unstructured":"Montagut C et al (2008) Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma. Cancer Res 68(12):4853\u20134861","journal-title":"Cancer Res"},{"issue":"1","key":"7764_CR43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12943-023-01903-x","volume":"22","author":"P Wang","year":"2023","unstructured":"Wang P et al (2023) Targeting CRAF kinase in anti-cancer therapy: progress and opportunities. Mol Cancer 22(1):208","journal-title":"Mol Cancer"},{"issue":"1","key":"7764_CR44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12920-019-0602-8","volume":"12","author":"T Lu","year":"2019","unstructured":"Lu T et al (2019) Whole-genome bisulfite sequencing in systemic sclerosis provides novel targets to understand disease pathogenesis. BMC Med Genomics 12(1):144","journal-title":"BMC Med Genomics"},{"issue":"4","key":"7764_CR45","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/01.HYP.0000063884.36641.63","volume":"41","author":"M Kawai","year":"2003","unstructured":"Kawai M et al (2003) Ral GDP dissociation stimulator and Ral GTPase are involved in myocardial hypertrophy. Hypertension 41(4):956\u2013962","journal-title":"Hypertension"},{"issue":"15","key":"7764_CR46","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","volume":"184","author":"MV Plikus","year":"2021","unstructured":"Plikus MV et al (2021) Fibroblasts: origins, definitions, and functions in health and disease. Cell 184(15):3852\u20133872","journal-title":"Cell"},{"issue":"7","key":"7764_CR47","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.bbagen.2016.03.023","volume":"1860","author":"Y Wang","year":"2016","unstructured":"Wang Y, Rouabhia M, Zhang Z (2016) Pulsed electrical stimulation benefits wound healing by activating skin fibroblasts through the TGF\u03b21\/ERK\/NF-\u03baB axis. Biochim Biophys Acta 1860(7):1551\u20131559","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"7764_CR48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/1541-7786.MCR-20-1022","volume":"19","author":"MS Crowe","year":"2021","unstructured":"Crowe MS et al (2021) RAF-mutant melanomas differentially depend on ERK2 over ERK1 to support aberrant MAPK pathway activation and cell proliferation. Mol Cancer Res 19(6):1063\u20131075","journal-title":"Mol Cancer Res"},{"issue":"10","key":"7764_CR49","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.266","volume":"6","author":"Z Wang","year":"2015","unstructured":"Wang Z et al (2015) RILP suppresses invasion of breast cancer cells by modulating the activity of RalA through interaction with RalGDS. Cell Death Dis 6(10):e1923","journal-title":"Cell Death Dis"},{"issue":"13","key":"7764_CR50","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/MCB.20.13.4658-4665.2000","volume":"20","author":"J Suzuki","year":"2000","unstructured":"Suzuki J et al (2000) Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts. Mol Cell Biol 20(13):4658\u20134665","journal-title":"Mol Cell Biol"},{"key":"7764_CR51","volume":"2020","author":"W Lin","year":"2020","unstructured":"Lin W et al (2020) Silencing ARAF suppresses the malignant phenotypes of gallbladder cancer cells. Biomed Res Int 2020:3235786","journal-title":"Biomed Res Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07764-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07764-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07764-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:41:39Z","timestamp":1769679699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07764-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7764"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07764-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}